Pyrotinib inhibits the tumorigenicity of HER2-positive non-small cell lung cancer by inducing ARIH1/ubiquitin/lysosome-dependent degradation of HER2.

ABSTRACT:

SUBMITTER: Li X 

PROVIDER: S-EPMC12698760 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature